WallStreetZenWallStreetZen

NASDAQ: TVTX
Travere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Travere Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Roy D. BaynesDirector2026-06-124,500$50.00
$225.00kSell
Roy D. BaynesDirector2026-06-124,500$21.38
$96.21kBuy
Timothy CoughlinDirector2026-06-1210,000$26.52
$265.20kBuy
Timothy CoughlinDirector2026-06-1210,000$50.08
$500.75kSell
Timothy CoughlinDirector2026-05-153,250$43.49
$141.34kSell
Jula InrigCHIEF MEDICAL OFFICER2026-05-06311$43.95
$13.67kSell
Elizabeth E. ReedChief Legal Officer and GC2026-05-062,076$43.95
$91.24kSell
William E. RoteChief Research Officer2026-05-062,763$43.95
$121.43kSell
Eric M. DubeCHIEF EXECUTIVE OFFICER2026-05-0622,500$43.95
$988.88kSell
Christopher R. ClineCHIEF FINANCIAL OFFICER2026-05-06310$43.95
$13.62kSell

1 of 13

TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVTX insiders and whales buy or sell their stock.

TVTX Shareholders

What type of owners hold Travere Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ruth Shepley52.69%49,000,000$2.70BInsider
Janus Henderson Group PLC12.28%11,419,586$629.79MInstitution
Fmr LLC11.79%10,967,967$604.88MInstitution
Blackrock Inc8.38%7,792,033$429.73MInstitution
State Street Corp5.33%4,959,988$273.54MInstitution
Armistice Capital LLC5.27%4,897,417$270.09MInstitution
Perceptive Advisors LLC4.45%4,142,551$228.46MInstitution
Vanguard Capital Management LLC4.35%4,045,812$223.13MInstitution
Nomura Asset Management International Inc3.52%3,270,513$180.37MInstitution
Broadfin Healthcare Master Fund Ltd2.86%2,658,854$146.64MInsider

1 of 3

TVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVTX63.57%36.43%Net SellingNet Selling
ORKA25.55%74.45%Net BuyingNet Selling
CRSP69.13%30.87%Net BuyingNet Selling
LGND18.49%81.51%Net SellingNet Selling
XENE97.56%2.44%Net SellingNet Selling
View Top Biotech Stocks

Travere Therapeutics Stock Ownership FAQ

Who owns Travere Therapeutics?

Travere Therapeutics (NASDAQ: TVTX) is owned by 108.99% institutional shareholders, 62.45% Travere Therapeutics insiders, and 0.00% retail investors. Ruth Shepley is the largest individual Travere Therapeutics shareholder, owning 49.00M shares representing 52.69% of the company. Ruth Shepley's Travere Therapeutics shares are currently valued at $2.70B.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.